Marko Roblek

775 total citations
17 papers, 524 citations indexed

About

Marko Roblek is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Marko Roblek has authored 17 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Marko Roblek's work include Immune cells in cancer (7 papers), Chemokine receptors and signaling (6 papers) and Cell Adhesion Molecules Research (4 papers). Marko Roblek is often cited by papers focused on Immune cells in cancer (7 papers), Chemokine receptors and signaling (6 papers) and Cell Adhesion Molecules Research (4 papers). Marko Roblek collaborates with scholars based in Germany, Switzerland and Austria. Marko Roblek's co-authors include Lubor Borsig, Mathias Heikenwälder, Anna Lorentzen, Maximilian Wolf, Alexander T. Bauer, Lucia Knopfová, Stefan W. Schneider, Martin Schlesinger, Daria E. Siekhaus and Attila Gyoergy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and PLoS ONE.

In The Last Decade

Marko Roblek

17 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Roblek Germany 11 227 223 213 93 75 17 524
Gwendoline Gros France 11 235 1.0× 314 1.4× 343 1.6× 47 0.5× 134 1.8× 19 630
Junfeng Wu China 14 252 1.1× 149 0.7× 190 0.9× 75 0.8× 62 0.8× 26 547
Hideo Takeshima Japan 13 219 1.0× 166 0.7× 137 0.6× 45 0.5× 69 0.9× 18 512
Anil Sehgal United States 13 362 1.6× 247 1.1× 171 0.8× 54 0.6× 61 0.8× 22 655
Tung Bui Canada 10 273 1.2× 195 0.9× 115 0.5× 38 0.4× 87 1.2× 12 470
Ligia I. Bastea United States 12 216 1.0× 204 0.9× 140 0.7× 82 0.9× 52 0.7× 19 456
Inbar Azoulay‐Alfaguter United States 11 200 0.9× 284 1.3× 283 1.3× 28 0.3× 35 0.5× 21 617
Tom Crabbe United Kingdom 10 305 1.3× 160 0.7× 179 0.8× 93 1.0× 153 2.0× 13 632
Kevin O’Hayer United States 10 315 1.4× 263 1.2× 113 0.5× 75 0.8× 88 1.2× 18 568
Mariam Gachechiladze Czechia 11 255 1.1× 207 0.9× 66 0.3× 67 0.7× 81 1.1× 30 486

Countries citing papers authored by Marko Roblek

Since Specialization
Citations

This map shows the geographic impact of Marko Roblek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Roblek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Roblek more than expected).

Fields of papers citing papers by Marko Roblek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Roblek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Roblek. The network helps show where Marko Roblek may publish in the future.

Co-authorship network of co-authors of Marko Roblek

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Roblek. A scholar is included among the top collaborators of Marko Roblek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Roblek. Marko Roblek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Madej, M. Gregor, Thomas Köcher, Harald H. Sitte, et al.. (2024). Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport. Proceedings of the National Academy of Sciences. 121(13). e2319686121–e2319686121. 1 indexed citations
2.
Gogh, Merel van, et al.. (2024). Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis. Neoplasia. 59. 101089–101089. 5 indexed citations
3.
Gyoergy, Attila, Maria Akhmanova, Markus Linder, et al.. (2022). Fos regulates macrophage infiltration against surrounding tissue resistance by a cortical actin-based mechanism in Drosophila. PLoS Biology. 20(1). e3001494–e3001494. 18 indexed citations
4.
Gyoergy, Attila, Jakob‐Wendelin Genger, Thomas Köcher, et al.. (2022). Macrophage mitochondrial bioenergetics and tissue invasion are boosted by an Atossa‐Porthos axis in Drosophila. The EMBO Journal. 41(12). e109049–e109049. 10 indexed citations
5.
Roblek, Marko, Merel van Gogh, Markus Daμμe, et al.. (2022). The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis. Frontiers in Oncology. 12. 777634–777634. 2 indexed citations
6.
Ştefănescu, Cristina, Merel van Gogh, Marko Roblek, Mathias Heikenwälder, & Lubor Borsig. (2021). TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms. Frontiers in Oncology. 11. 765151–765151. 4 indexed citations
7.
Roblek, Marko, Attila Gyoergy, Aparna Ratheesh, et al.. (2019). A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion. eLife. 8. 20 indexed citations
8.
Roblek, Marko, Cristina Ştefănescu, Christian Gorzelanny, et al.. (2018). CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis. Molecular Cancer Research. 17(3). 783–793. 45 indexed citations
9.
Gyoergy, Attila, Marko Roblek, Aparna Ratheesh, et al.. (2018). Tools Allowing Independent Visualization and Genetic Manipulation ofDrosophila melanogasterMacrophages and Surrounding Tissues. G3 Genes Genomes Genetics. 8(3). 845–857. 39 indexed citations
10.
Häuselmann, Irina, Marko Roblek, Volker Huck, et al.. (2016). Monocyte Induction of E-Selectin–Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade. Cancer Research. 76(18). 5302–5312. 65 indexed citations
11.
Roblek, Marko, Tiziana Adage, Mathias Heikenwälder, et al.. (2016). Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding. Neoplasia. 18(1). 49–59. 27 indexed citations
12.
Yang, Yang, Christian Gorzelanny, Alexander T. Bauer, et al.. (2015). Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity. Oncogene. 34(47). 5832–5842. 39 indexed citations
13.
Roblek, Marko, Manuela Călin, Martin Schlesinger, et al.. (2015). Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis. Journal of Controlled Release. 220(Pt A). 341–347. 24 indexed citations
14.
Schlesinger, Martin, Reiner Zeisig, Manuela Călin, et al.. (2015). Inhibition of chemokine receptor CCR2 reduces sarcoma cell transendothelial migration and metastasis to the lungs. International Journal of Clinical Pharmacology and Therapeutics. 53(12). 1046–1048. 1 indexed citations
15.
Schlesinger, Martin, Marko Roblek, Annamaria Naggi, et al.. (2014). The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. Thrombosis Research. 133(5). 855–862. 32 indexed citations
16.
Borsig, Lubor, Maximilian Wolf, Marko Roblek, Anna Lorentzen, & Mathias Heikenwälder. (2013). Inflammatory chemokines and metastasis—tracing the accessory. Oncogene. 33(25). 3217–3224. 177 indexed citations
17.
Roblek, Marko, et al.. (2010). Monoclonal Antibodies Specific for Disease-Associated Point-Mutants: Lamin A/C R453W and R482W. PLoS ONE. 5(5). e10604–e10604. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gwendoline Gros Breakdown of academic impact, for papers by Junfeng Wu Breakdown of academic impact, for papers by Hideo Takeshima Breakdown of academic impact, for papers by Anil Sehgal Breakdown of academic impact, for papers by Tung Bui Breakdown of academic impact, for papers by Ligia I. Bastea Breakdown of academic impact, for papers by Inbar Azoulay‐Alfaguter Breakdown of academic impact, for papers by Tom Crabbe Breakdown of academic impact, for papers by Kevin O’Hayer Breakdown of academic impact, for papers by Mariam Gachechiladze
Rankless by CCL
2026